These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35221319)

  • 41. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial.
    Kumar S; Bansal A; Chakrabarti A; Singhi S
    Crit Care Med; 2013 Feb; 41(2):565-72. PubMed ID: 23361033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
    Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
    Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supplementation with Bifidobacterium longum Bar33 and Lactobacillus helveticus Bar13 mixture improves immunity in elderly humans (over 75 years) and aged mice.
    Finamore A; Roselli M; Donini L; Brasili DE; Rami R; Carnevali P; Mistura L; Pinto A; Giusti A; Mengheri E
    Nutrition; 2019; 63-64():184-192. PubMed ID: 31029046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preterm Infant Fecal Microbiota and Metabolite Profiles Are Modulated in a Probiotic Specific Manner.
    Larke JA; Kuhn-Riordon K; Taft DH; Sohn K; Iqbal S; Underwood MA; Mills DA; Slupsky CM
    J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):535-542. PubMed ID: 35881967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
    Costeloe K; Hardy P; Juszczak E; Wilks M; Millar MR;
    Lancet; 2016 Feb; 387(10019):649-660. PubMed ID: 26628328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
    Murphy R; Morgan XC; Wang XY; Wickens K; Purdie G; Fitzharris P; Otal A; Lawley B; Stanley T; Barthow C; Crane J; Mitchell EA; Tannock GW
    Benef Microbes; 2019 Feb; 10(1):5-17. PubMed ID: 30574802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing
    Wieërs G; Verbelen V; Van Den Driessche M; Melnik E; Vanheule G; Marot JC; Cani PD
    Front Public Health; 2020; 8():578089. PubMed ID: 33763399
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut.
    Panigrahi P; Parida S; Pradhan L; Mohapatra SS; Misra PR; Johnson JA; Chaudhry R; Taylor S; Hansen NI; Gewolb IH
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):45-53. PubMed ID: 18607268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
    de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
    Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of mother's intestinal microbiota on gut colonization in the infant.
    Grönlund MM; Grześkowiak Ł; Isolauri E; Salminen S
    Gut Microbes; 2011; 2(4):227-33. PubMed ID: 21983067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
    Patole S; Keil AD; Chang A; Nathan E; Doherty D; Simmer K; Esvaran M; Conway P
    PLoS One; 2014; 9(3):e89511. PubMed ID: 24594833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial.
    Jacobs SE; Tobin JM; Opie GF; Donath S; Tabrizi SN; Pirotta M; Morley CJ; Garland SM;
    Pediatrics; 2013 Dec; 132(6):1055-62. PubMed ID: 24249817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial.
    Kukkonen K; Savilahti E; Haahtela T; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Kuitunen M
    J Allergy Clin Immunol; 2007 Jan; 119(1):192-8. PubMed ID: 17208601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.
    McCarthy J; O'Mahony L; O'Callaghan L; Sheil B; Vaughan EE; Fitzsimons N; Fitzgibbon J; O'Sullivan GC; Kiely B; Collins JK; Shanahan F
    Gut; 2003 Jul; 52(7):975-80. PubMed ID: 12801954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiota Supplementation with
    Alcon-Giner C; Dalby MJ; Caim S; Ketskemety J; Shaw A; Sim K; Lawson MAE; Kiu R; Leclaire C; Chalklen L; Kujawska M; Mitra S; Fardus-Reid F; Belteki G; McColl K; Swann JR; Kroll JS; Clarke P; Hall LJ
    Cell Rep Med; 2020 Aug; 1(5):100077. PubMed ID: 32904427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer.
    Zaharuddin L; Mokhtar NM; Muhammad Nawawi KN; Raja Ali RA
    BMC Gastroenterol; 2019 Jul; 19(1):131. PubMed ID: 31340751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
    Tremblay A; Fatani A; Ford AL; Piano A; Nagulesapillai V; Auger J; MacPherson CW; Christman MC; Tompkins TA; Dahl WJ
    J Diet Suppl; 2021; 18(3):227-247. PubMed ID: 32306803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial.
    Shadnoush M; Hosseini RS; Khalilnezhad A; Navai L; Goudarzi H; Vaezjalali M
    Korean J Gastroenterol; 2015 Apr; 65(4):215-21. PubMed ID: 25896155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: a single arm open label trial.
    Rodenes-Gavidia A; Lamelas A; Bloor S; Hobson A; Treadway S; Haworth J; Vijayakumar V; Naghibi M; Day R; Chenoll E
    Front Cell Infect Microbiol; 2023; 13():1240267. PubMed ID: 37841999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.